Business Wire

Packaging Redesigns See 4% Average Volume Lift, NIQ Finds

20.8.2026 12:00:00 CEST | Business Wire | Press Release

Share

NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today named the winners of its ninth annual Design Impact Awards, recognizing eight package redesigns that combined stronger shopper experiences with measurable commercial performance. Across nearly a decade of NIQ Design Impact Award winners, recognized redesigns have been associated with an average volume increase of approximately 4%.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260819712595/en/

NIQ Design Impact Awards 2026

The 2026 NIQ Design Impact Award Winners*:

  • Aval French Cider (Parent Company: Aval Cider; Country: USA)
  • Liquid I.V. (Parent Company: Unilever; Country: USA)
  • Root & Splendor (Parent Company: Root & Splendor; Country: USA)
  • Hostess Cakes (Parent Company: The J.M. Smucker Company; Country: USA)
  • Back to Nature (Parent Company: Barilla Group; Country: USA)
  • John West Tuna Chunks (Parent Company: Thai Union; Country: UK)
  • Country Fresh Ice Cream (Parent Company: DairyMaid; Country: South Africa)
  • Rustica Pizza (Parent Company: McCain Foods; Country: USA)

"The Design Impact Awards reinforce the critical role packaging plays in influencing shopper decisions and driving business growth," said Andrea Fraboni, Vice President & Global Leader, Pack & Design Solutions, NIQ. "Packaging has seconds to do its job. The strongest redesigns make products easier to notice, understand and choose while preserving the distinctive brand cues consumers recognize. This year's winners demonstrate that packaging design isn’t simply aesthetic. When done well, it can be a meaningful driver of shopper engagement and business growth."

Following a review of submissions from around the world, NIQ's Pack & Design experts evaluated entries against key packaging principles and the role packaging plays throughout the shopper journey. NIQ's proprietary Retail Measurement Services (RMS) data was used to identify brands that achieved measurable sales growth following the launch of their updated package designs.

While this year's winning redesigns spanned categories ranging from beverages and household products to frozen foods and snacks, they shared a common objective: making the shopper journey easier. Through stronger shelf visibility, clearer information hierarchy, simplified communication, and more distinctive branding, each redesign helped shoppers notice, understand and choose products with less effort.

NIQ's Pack & Design Solutions practice helps manufacturers identify, evaluate and optimize packaging that drives shopper engagement and business performance. By combining neuroscience-based methods, including Real System 1 (EEG) research, with behavioral and survey-based approaches, NIQ provides actionable insights that help brands validate packaging concepts and make more confident design decisions.

To learn more about the winning redesigns, the packaging principles behind their success, upcoming regional presentations, and NIQ's Pack & Design solutions, visit the NIQ Design Impact Awards webpage.

*All products and company names are trademarks of their respective holders. No affiliation or endorsement is expressed or implied.

About NIQ

NielsenIQ (NYSE: NIQ) is a leading consumer intelligence company, delivering the most complete and trusted understanding of consumer buying behavior and revealing new pathways to growth. By combining an unmatched global data footprint and granular consumer and retail measurement with decades of AI modeling expertise, NIQ builds decision systems that help companies turn complex data into confident action.

With operations in more than 90 countries, NIQ covers approximately 82% of the world’s population and more than $7.4 trillion in global consumer spend. Through cloud-based platforms, advanced analytics and AI-driven insights, NIQ delivers The Full View™—helping brands and retailers understand what consumers buy, why they buy it, and what to do next.

For more information, please visit www.niq.com.

NIQ-General

© 2026 Nielsen Consumer LLC. All Rights Reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260819712595/en/

Contacts

media.relations@nielseniq.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SLB Launches ExaCT Electrical Downhole CT Control System24.8.2026 13:02:00 CEST | Press Release

SLB (NYSE: SLB) today launched the ExaCT™ electrical downhole coiled tubing (CT) control system, an advanced intervention platform that introduces real-time electrical control to coiled tubing operations. By replacing pressure-dependent hydraulic actuation with electrical communication, power delivery and telemetry, the ExaCT system gives operators greater visibility, precision and control, helping improve intervention execution and reservoir access. The ExaCT system combines electrical power, telemetry and downhole measurements to enable communication with, actuation of and verification of downhole tools throughout an intervention. Continuous communication across the toolstring enables on-demand tool actuation across a wide range of intervention applications, including extended-reach and multilateral wells. The increased precision and control provided by the system help operators optimize reservoir access, improve production performance and maximize recovery. "Operators are asking int

Wolters Kluwer Transforms Trusted Legal Content Into Structured, AI-Ready Intelligence That Powers the Next Wave of Legal AI24.8.2026 13:01:00 CEST | Press Release

Wolters KluwerLegal & Regulatory today announced the next evolution of Libra by Wolters Kluwer, its all-in-one Legal AI Workspace. By transforming authoritative legal sources, expert commentaries, and practical guidance into structured legal intelligence, Wolters Kluwer is making the relationships across the full breadth of its expert legal sources more explicit. This will enable deeper contextual research, more comprehensible answers, and workflow-ready results across legal work. Following the integration of Wolters Kluwer content into the Libra AI workspace in the first half of 2026, laws, rulings, expert commentaries, and practical guidance will now be linked to one another and to the matter at hand, creating a connected knowledge graph of expert-curated and authoredlegal knowledge that AI can reason over. For customers, this means research that surfaces the right authority faster, answers with even clearer reasoning and sources, drafting guided by matter-specific context, and great

Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization24.8.2026 10:00:00 CEST | Press Release

Daiichi Sankyo (TSE: 4568) today announced the appointment of Markus Kosch, MD, as Head of Europe Business, effective April 1, 2027. In this role, he will lead the company's European business within the new globally integrated Commercialization Unit and serve as General Manager of Daiichi Sankyo Europe GmbH, with legal responsibility for the company in Europe. The appointment reflects the next phase of growth of Daiichi Sankyo under its Five-Year Business Plan and the establishment of a new Commercialization Unit. Within this new structure, Markus Kosch will bring together the Oncology and Specialty businesses in Europe under one integrated leadership model to help bring innovative medicines to more patients across the region. For the past five years, Markus Kosch has led the Daiichi Sankyo Oncology Business Division in Europe and Canada, overseeing a period of significant growth and preparing the organization for an increasingly expanding oncology portfolio. Prior to joining Daiichi S

European Commission Approves DAYBU ® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union24.8.2026 09:01:00 CEST | Press Release

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older, making it the first and only treatment approved for Rett syndrome in the European Union (EU). “The approval of DAYBU marks a significant milestone for the Rett syndrome community in the EU and advances our mission to bring this innovative treatment to patients and families who have long faced a profound unmet medical need,” said Catherine Owen Adams, Acadia’s Chief Executive Officer. “For people living with Rett syndrome, a devastating rare neurodevelopmental disorder, there have been no approved treatment options in the EU. We are proud to make DAYBU available and look forward to supporting patients, caregivers, and healthcare providers gain access to treatment." The DAYBU marketing authorization in the EU is prim

ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 08:36:00 CEST | Press Release

Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly as possible. “Our discovery of the first orexin agonist is a successful representation of Japan-originated science that will directly impact people around the world living with narcolepsy type 1,” said Julie Kim, president and chief executive officer of Takeda. “With the potential to redefine narcolepsy type 1 care, ORZEYFUL is the first validation of our broader orexin strategy, demonstrating how scientifi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye